Kyle Rose
Stock Analyst at Canaccord Genuity
(3.38)
# 875
Out of 4,853 analysts
114
Total ratings
53.26%
Success rate
13.82%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $30.30 | -10.89% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $317.16 | +2.16% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $383.10 | +13.55% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $59.55 | +19.23% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $31.60 | +124.68% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.34 | +53.42% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.60 | +525.00% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $12.44 | +76.85% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $85.74 | +74.95% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $7.65 | +3,429.41% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $19.06 | +41.66% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.95 | +669.23% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $10.80 | +38.89% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $178.56 | -31.68% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $2.91 | +37.46% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.49 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $91.92 | +35.99% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $30.30
Upside: -10.89%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $317.16
Upside: +2.16%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $383.10
Upside: +13.55%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $59.55
Upside: +19.23%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $31.60
Upside: +124.68%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.34
Upside: +53.42%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.60
Upside: +525.00%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $12.44
Upside: +76.85%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $85.74
Upside: +74.95%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $7.65
Upside: +3,429.41%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $19.06
Upside: +41.66%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.95
Upside: +669.23%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $10.80
Upside: +38.89%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $178.56
Upside: -31.68%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $2.91
Upside: +37.46%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.49
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $91.92
Upside: +35.99%